Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Cirrhosis

Free Subscription Articles published in Clin Res Hepatol Gastroenterol Retrieve available abstracts of 95 articles: HTML format

Single Articles

May 2024
1. CHANG G, Sun J, Li J, Li T, et al
   Effect of Probiotics on Portal Hypertension (PH) with Cirrhosis: A Systematic Review and Meta-Analysis.
   Clin Res Hepatol Gastroenterol. 2024 May 1:102361.
   PubMed     Abstract available
   
   
   
2. LI R, Sarin S
   The smoker's paradox in transjugular intrahepatic portosystemic shunt procedure: A national inpatient sample analysis from 2015 to 2020.
   Clin Res Hepatol Gastroenterol. 2024;48:102323.
   PubMed     Abstract available
   
   
   
3. LIANG Y, Li J, Zhang Z, Jiang T, et al
   Extrahepatic conditions of primary biliary cholangitis: A systematic review and meta-analysis of prevalence and risk.
   Clin Res Hepatol Gastroenterol. 2024;48:102321.
   PubMed     Abstract available
   
   
   April 2024
4. PATEL K, Twohig P, Peeraphatdit T, Stohs EJ, et al
   Outcomes and factors associated with cryptococcal disease among cirrhotics: A study of the national inpatient sample 2005 to 2014.
   Clin Res Hepatol Gastroenterol. 2024;48:102337.
   PubMed     Abstract available
   
   
   February 2024
5. HE Q, Xiong Y, Xia P, Yang X, et al
   Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
   Clin Res Hepatol Gastroenterol. 2024;48:102283.
   PubMed     Abstract available
   
   
   
6. XIE C, Liu K, Xie Y, Liu S, et al
   Metabolism-related signalling pathways involved in the pathogenesis and development of metabolic dysfunction-associated steatotic liver disease.
   Clin Res Hepatol Gastroenterol. 2024;48:102264.
   PubMed     Abstract available
   
   
   January 2024
7. KUMAR MS
   Paneth cell: The missing link between obesity, MASH and portal hypertension.
   Clin Res Hepatol Gastroenterol. 2024;48:102259.
   PubMed     Abstract available
   
   
   
8. SEXTON F, Shanahan W, Ryan JD
   Xanthoma striatum palmare: Getting a handle on hyperlipidaemia in primary biliary cholangitis.
   Clin Res Hepatol Gastroenterol. 2024;48:102255.
   PubMed    
   
   
   December 2023
9. THABUT D, Roux J, Simon-Sultanik P, Tamberou C, et al
   Population characteristics, healthcare pathways and outcomes of patients with cirrhosis hospitalized with overt hepatic encephalopathy in France: a study of the French Hospital-Discharge Database.
   Clin Res Hepatol Gastroenterol. 2023 Dec 26:102274.
   PubMed     Abstract available
   
   
   
10. JANG H, Han N, Staatz CE, Kwak JH, et al
    Effect on lipid profile and clinical outcomes of obeticholic acid for the treatment of primary biliary cholangitis and metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2023;47:102227.
    PubMed     Abstract available
    
    
    
11. JIANG R, Zhou Y, Han L, Hong Z, et al
    Serum vitamin D is associated with ultrasound-defined hepatic fibrosis.
    Clin Res Hepatol Gastroenterol. 2023;47:102228.
    PubMed     Abstract available
    
    
    
12. DONATI A, Henrion J, Regnier M, Deltenre P, et al
    Abstinence is associated with better outcomes in patients with alcohol-related hepatocellular carcinoma: Results of an observational study.
    Clin Res Hepatol Gastroenterol. 2023;47:102225.
    PubMed     Abstract available
    
    
    October 2023
13. CHAIBI S, Larrey E, Couty JP, Sultanik P, et al
    Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCC.
    Clin Res Hepatol Gastroenterol. 2023;47:102199.
    PubMed     Abstract available
    
    
    
14. DUMONT C, Lanthier N, Dahlqvist G
    Fibrosis and steatosis of the liver graft: Are non-invasive tests useful? A short review.
    Clin Res Hepatol Gastroenterol. 2023;47:102194.
    PubMed     Abstract available
    
    
    September 2023
15. MARTINO VD, Questiaux J, Lemagoarou T, Weil D, et al
    Granulocyte Colony Stimulating Factor in decompensated cirrhosis, acute alcoholic hepatitis, and acute-on-chronic liver failure: a comprehensive meta-analysis of randomized controlled trials.
    Clin Res Hepatol Gastroenterol. 2023 Sep 14:102207.
    PubMed     Abstract available
    
    
    
16. KOUNIS I, Sacleux SC, Ordan MA, Andre S, et al
    Efficiency and safety of total plasma exchange in critically ill cirrhotic patients with acute on chronic liver failure: A pilot study.
    Clin Res Hepatol Gastroenterol. 2023;47:102206.
    PubMed     Abstract available
    
    
    August 2023
17. LU M, Zhu M, Li H, Wang Q, et al
    Factors associated with discordance in the assessment of fibrosis stage between transient elastography and liver biopsy in NAFLD patients.
    Clin Res Hepatol Gastroenterol. 2023;47:102183.
    PubMed     Abstract available
    
    
    
18. MAMANDIPOOR B, Wernly S, Semmler G, Flamm M, et al
    Machine learning models predict liver steatosis but not liver fibrosis in a prospective cohort study.
    Clin Res Hepatol Gastroenterol. 2023;47:102181.
    PubMed     Abstract available
    
    
    
19. CALLERI A, Alessandria C
    Renal damage in Hepatorenal Syndrome: A still unsolved issue.
    Clin Res Hepatol Gastroenterol. 2023;47:102178.
    PubMed     Abstract available
    
    
    June 2023
20. WANG X, Xu GH, Yu J, Li H, et al
    When cirrhosis meets paroxysmal nocturnal hemoglobinuria: What kind of "fireworks" scenario will occur?
    Clin Res Hepatol Gastroenterol. 2023;47:102173.
    PubMed    
    
    
    May 2023
21. YAICI L, Gatouillat G, Andreoletti L, N'Guyen Y, et al
    Chronic Hepatitis Delta cirrhosis cured by adapting PEG-IFNalpha-2a + tenofovir disoproxil fumarate treatment duration until HBsAg loss.
    Clin Res Hepatol Gastroenterol. 2023 May 25:102148.
    PubMed     Abstract available
    
    
    
22. RAVAIOLI F, Berger A, Farcau O, Colecchia A, et al
    Individual and population screening of varices needing treatment by a simple, safe and accurate test.
    Clin Res Hepatol Gastroenterol. 2023;47:102123.
    PubMed     Abstract available
    
    
    
23. MALKANI KV, Jesudian AB, Luo JJ, Schonfeld EA, et al
    Noncirrhotic portal hypertension in primary biliary cholangitis with coexisting CREST syndrome.
    Clin Res Hepatol Gastroenterol. 2023;47:102114.
    PubMed     Abstract available
    
    
    
24. MEURER A, Antoni C, Ebert MP, Trimborn A, et al
    Spontaneous bacterial peritonitis caused by Listeria monocytogenes: A rare infection with very high leukocyte counts in ascitic fluid-case report and review of the literature.
    Clin Res Hepatol Gastroenterol. 2023;47:102130.
    PubMed     Abstract available
    
    
    April 2023
25. SASAKI M, Sato Y, Nakanuma Y
    An involvement of Hippo-yes-associated protein pathway in biliary epithelial senescence in primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2023;47:102106.
    PubMed     Abstract available
    
    
    March 2023
26. CAO L, Qu N, Wang X, Chen L, et al
    The function of long non-coding RNA in non-alcoholic fatty liver disease.
    Clin Res Hepatol Gastroenterol. 2023;47:102095.
    PubMed     Abstract available
    
    
    February 2023
27. IANNONE G, Pompili E, Renzulli M, Caraceni P, et al
    A case of peri-stomal ectopic variceal bleeding in a patient with decompensated cirrhosis treated with TIPS placement.
    Clin Res Hepatol Gastroenterol. 2023 Feb 24:102098.
    PubMed     Abstract available
    
    
    
28. MURALI AR, Prakash S, Sanchez AJ
    Alpha-1-Antitrypsin Pi*MZ variant increases risk of developing hepatic events in nonalcoholic fatty liver disease patients().
    Clin Res Hepatol Gastroenterol. 2023;47:102066.
    PubMed     Abstract available
    
    
    January 2023
29. BECCHETTI C, Lange NF, Delgado MG, Bronnimann MP, et al
    2D shear wave elastography of the rectus femoris muscle in patients with cirrhosis: feasibility and clinical findings. A pilot study.
    Clin Res Hepatol Gastroenterol. 2023 Jan 16:102080.
    PubMed     Abstract available
    
    
    
30. OKADA S, Kashima K, Okada K, Okada J, et al
    Aging affects FIB-4 index in the general population without pre-existing diseases: Analysis of a cohort of healthy individuals who underwent annual health checkups for 10 consecutive years.
    Clin Res Hepatol Gastroenterol. 2023;47:102058.
    PubMed    
    
    
    October 2022
31. LIU X, Zhou J, Zhu L, Zhang X, et al
    Diagnostic accuracy of apparent diffusion coefficient values combined with gamma-glutamyl transpeptidase-to-platelet ratio parameters for predicting hepatitis B-related fibrosis.
    Clin Res Hepatol Gastroenterol. 2022;46:101968.
    PubMed     Abstract available
    
    
    
32. LIU J, Ma Y, Han P, Wang J, et al
    Hepatic steatosis leads to overestimation of liver stiffness measurement in both chronic hepatitis B and metabolic-associated fatty liver disease patients.
    Clin Res Hepatol Gastroenterol. 2022;46:101957.
    PubMed     Abstract available
    
    
    
33. DING Y, Jiang L, Wang Q, Zhao W, et al
    The prevalence of nonalcoholic fatty liver disease in Chinese adults screened by vibration controlled transient elastography and its diagnostic discrepancy compared with ultrasound.
    Clin Res Hepatol Gastroenterol. 2022;46:101951.
    PubMed     Abstract available
    
    
    
34. LEROY V, Chevaliez S, Decraecker M, Roulot D, et al
    Non-invasive diagnosis and follow-up of chronic infection with hepatitis B virus.
    Clin Res Hepatol Gastroenterol. 2022;46:101773.
    PubMed     Abstract available
    
    
    
35. THABUT D, Weil D, Bouzbib C, Rudler M, et al
    Non-invasive diagnosis and follow-up of portal hypertension.
    Clin Res Hepatol Gastroenterol. 2022;46:101767.
    PubMed     Abstract available
    
    
    September 2022
36. COILLY A, Sebagh M, Fougerou-Leurent C, Pageaux GP, et al
    HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation.
    Clin Res Hepatol Gastroenterol. 2022 Sep 16:102024.
    PubMed     Abstract available
    
    
    August 2022
37. SOURIANARAYANANE A, McCullough AJ
    Accuracy of steatosis and fibrosis NAFLD scores in relation to vibration controlled transient elastography: An NHANES analysis.
    Clin Res Hepatol Gastroenterol. 2022;46:101997.
    PubMed     Abstract available
    
    
    
38. CALES P, Ravaioli F, Berger A, Farcau O, et al
    Comparison of screening strategies with two new tests to score and diagnose varices needing treatment.
    Clin Res Hepatol Gastroenterol. 2022;46:101925.
    PubMed     Abstract available
    
    
    May 2022
39. TRIPON S, Bilbault P, Fabacher T, Lefebvre N, et al
    Abnormal liver tests and non-alcoholic fatty liver disease predict disease progression and outcome of patients with COVID-19.
    Clin Res Hepatol Gastroenterol. 2022;46:101894.
    PubMed     Abstract available
    
    
    April 2022
40. BOILLOT O, Chopinet S, Gregoire E, Milot L, et al
    Partial splenectomy in children undergoing liver transplantation or venous shunt for severe hypersplenism: a case control comparative study.
    Clin Res Hepatol Gastroenterol. 2022 Apr 21:101929.
    PubMed     Abstract available
    
    
    
41. WARASNHE K, Ozcay F, Aydin HI, Ozgun G, et al
    A Novel Mutation in TRMT5 Associated with Idiopathic Non-Cirrhotic Portal Hypertension and Hepatopulmonary Syndrome: Case Report of Two Siblings.
    Clin Res Hepatol Gastroenterol. 2022 Apr 20:101928.
    PubMed     Abstract available
    
    
    
42. AZZI J, Dorival C, Cagnot C, Fontaine H, et al
    Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response.
    Clin Res Hepatol Gastroenterol. 2022 Apr 8:101923.
    PubMed     Abstract available
    
    
    
43. DUCLOS-VALLEE JC, Debray D, De Martin E, Beux EL, et al
    Best practice guidelines for France regarding the diagnosis and management of autoimmune hepatitis.
    Clin Res Hepatol Gastroenterol. 2022;46:101871.
    PubMed    
    
    
    
44. WASUWANICH P, So JM, Scheimann AO, Spahic H, et al
    Hepatic and non-hepatic hydrothorax in pediatric ascites.
    Clin Res Hepatol Gastroenterol. 2022;46:101868.
    PubMed     Abstract available
    
    
    
45. ARTRU F, Moschouri E, Denys A
    Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: Indications, technique, and outcomes beyond Budd-Chiari syndrome.
    Clin Res Hepatol Gastroenterol. 2022;46:101858.
    PubMed     Abstract available
    
    
    
46. ZHANG C, Zhang B, Chen A, Yin Q, et al
    Trans-anethole attenuates diet-induced nonalcoholic steatohepatitis through suppressing TGF-beta-mediated fibrosis.
    Clin Res Hepatol Gastroenterol. 2022;46:101833.
    PubMed     Abstract available
    
    
    March 2022
47. DANA J, Girard M, Franchi-Abella S, Berteloot L, et al
    Comparison of Transient Elastography, ShearWave Elastography, Magnetic Resonance Elastography and FibroTest as routine diagnostic markers for assessing liver fibrosis in children with Cystic Fibrosis.
    Clin Res Hepatol Gastroenterol. 2022;46:101855.
    PubMed     Abstract available
    
    
    
48. TANG J, Chen C, Zhou M, Wang J, et al
    NLR contributed to the diagnosis and detection of nonalcoholic fatty liver disease: A meta - analysis.
    Clin Res Hepatol Gastroenterol. 2022;46:101847.
    PubMed    
    
    
    
49. SCHAEFER A, Journaux M, Mourabit HE, Mouri S, et al
    A systemic mechanism of increased transendothelial migration of leukocytes through the blood-brain barrier in hepatic encephalopathy.
    Clin Res Hepatol Gastroenterol. 2022;46:101801.
    PubMed     Abstract available
    
    
    February 2022
50. KAPS L, Hildebrand K, Nagel M, Michel M, et al
    Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosis.
    Clin Res Hepatol Gastroenterol. 2022 Feb 3:101873.
    PubMed     Abstract available
    
    
    
51. VITELLIUS C, Paisant A, Lannes A, Chaigneau J, et al
    Liver fibrosis staging by computed tomography: Prospective randomized multicentric evaluation of image analyses.
    Clin Res Hepatol Gastroenterol. 2022;46:101797.
    PubMed     Abstract available
    
    
    
52. HUANG L, Liu J, Bie C, Liu H, et al
    Advances in cell death - related signaling pathways in acute-on-chronic liver failure.
    Clin Res Hepatol Gastroenterol. 2022;46:101783.
    PubMed     Abstract available
    
    
    January 2022
53. DE LEDINGHEN V
    Non-invasive diagnosis and follow-up of chronic liver disease.
    Clin Res Hepatol Gastroenterol. 2022;46:101763.
    PubMed    
    
    
    
54. NAHON P, Aube C, Moga L, Chalaye J, et al
    Non-invasive diagnosis and follow-up of primary malignant liver tumours.
    Clin Res Hepatol Gastroenterol. 2022;46:101766.
    PubMed     Abstract available
    
    
    
55. CORPECHOT C, Heurgue A, Tanne F, Potier P, et al
    Non-invasive diagnosis and follow-up of primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2022;46:101770.
    PubMed     Abstract available
    
    
    
56. BOURSIER J, Guillaume M, Bouzbib C, Lannes A, et al
    Non-invasive diagnosis and follow-up of non-alcoholic fatty liver disease.
    Clin Res Hepatol Gastroenterol. 2022;46:101769.
    PubMed     Abstract available
    
    
    
57. RAUTOU PE, Elkrief L, Decraecker M, Ollivier-Hourmand I, et al
    Non-invasive diagnosis and follow-up of vascular liver diseases.
    Clin Res Hepatol Gastroenterol. 2022;46:101764.
    PubMed     Abstract available
    
    
    
58. LEMOINNE S, Heurgue A, Bouzbib C, Hanslik B, et al
    Non-invasive diagnosis and follow-up of autoimmune hepatitis.
    Clin Res Hepatol Gastroenterol. 2022;46:101772.
    PubMed     Abstract available
    
    
    
59. BOURSIER J, Decraecker M, Bourliere M, Bureau C, et al
    Quality criteria for the measurement of liver stiffness.
    Clin Res Hepatol Gastroenterol. 2022;46:101761.
    PubMed     Abstract available
    
    
    
60. CHEN BR, Pan CQ
    Non-invasive assessment of fibrosis and steatosis in pediatric non-alcoholic fatty liver disease.
    Clin Res Hepatol Gastroenterol. 2022;46:101755.
    PubMed     Abstract available
    
    
    
61. MAO QG, Liang HQ, Yin YL, Tang JM, et al
    Comparison of Interferon-alpha-based therapy and nucleos(t)ide analogs in preventing adverse outcomes in patients with chronic hepatitis B.
    Clin Res Hepatol Gastroenterol. 2022;46:101758.
    PubMed     Abstract available
    
    
    
62. ZIMMER V, Emrich K
    Nodular gastric antral vascular ectasia: Distinct portal hypertensive hyperplastic polyp lesions.
    Clin Res Hepatol Gastroenterol. 2022;46:101745.
    PubMed    
    
    
    November 2021
63. SOBOTKA LA, Mumtaz K, Hinton A, Conteh LF, et al
    The Time to Advocate for Influenza Vaccines in Patients with Cirrhosis is Now.
    Clin Res Hepatol Gastroenterol. 2021 Nov 20:101838.
    PubMed     Abstract available
    
    
    
64. TUTUNCHI H, Naeini F, Ebrahimi-Mameghani M, Najafipour F, et al
    Metabolically healthy and unhealthy obesity and the progression of liver fibrosis: A cross-sectional study.
    Clin Res Hepatol Gastroenterol. 2021;45:101754.
    PubMed     Abstract available
    
    
    October 2021
65. ZHANG L, Zhou Y, Zhang J
    An incidental hepatic lesion in a cirrhotic liver.
    Clin Res Hepatol Gastroenterol. 2021 Oct 28:101825.
    PubMed    
    
    
    
66. MOGA L, Robic MA, Blasco-Perrin H, Cabarrou P, et al
    Acute kidney injury in patients with cirrhosis: prospective longitudinal study in 405 patients.
    Clin Res Hepatol Gastroenterol. 2021 Oct 27:101822.
    PubMed     Abstract available
    
    
    
67. ARTZNER T, Legeai C, Antoine C, Jasseron C, et al
    Liver transplantation for critically ill cirrhotic patients: results from the French transplant registry.
    Clin Res Hepatol Gastroenterol. 2021 Oct 1:101817.
    PubMed     Abstract available
    
    
    September 2021
68. WAHLIN S, Andersson J
    Liver health literacy and social stigma of liver disease: A general population e-survey.
    Clin Res Hepatol Gastroenterol. 2021;45:101750.
    PubMed     Abstract available
    
    
    August 2021
69. BOUZBIB C, El Mourabit H, Wendum D, Lasnier E, et al
    ATP-binding cassette transporters expression in rats with cirrhosis and hepatic encephalopathy.
    Clin Res Hepatol Gastroenterol. 2021 Aug 9:101784.
    PubMed     Abstract available
    
    
    July 2021
70. TRAN A, Shili-Masmoudi S, Moga L, Chevaliez S, et al
    NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF CHRONIC INFECTION WITH HEPATITIS C VIRUS.
    Clin Res Hepatol Gastroenterol. 2021 Jul 28:101771.
    PubMed     Abstract available
    
    
    
71. VILLERET F, Dumortier J, Erard-Poinsot D
    How will NAFLD change the liver transplant landscape in the 2020s?
    Clin Res Hepatol Gastroenterol. 2021 Jul 23:101759.
    PubMed     Abstract available
    
    
    
72. LANTHIER N, Starkel P, Dahlqvist G
    Muscle mass depletion in chronic liver diseases: An accelerated model of aging or a distinct entity?
    Clin Res Hepatol Gastroenterol. 2021;45:101721.
    PubMed     Abstract available
    
    
    
73. CAMPOS-MURGUIA A, Valdez-Hernandez P, Cordova-Gallardo J, Arteaga-Vazquez J, et al
    Prevalence and clinical characteristics of alpha-1 antitrypsin deficiency in liver explants in a Mexican cohort.
    Clin Res Hepatol Gastroenterol. 2021;45:101519.
    PubMed     Abstract available
    
    
    June 2021
74. QU Y, Li T, Lin C, Liu F, et al
    Animal Naming Test for the Assessment of Minimal Hepatic Encephalopathy in Asian Cirrhotic Populations.
    Clin Res Hepatol Gastroenterol. 2021 Jun 3:101729.
    PubMed     Abstract available
    
    
    
75. RAZAQ S, Kara M, Ozcakar L
    Measure Grip Strength, Gait Speed and Quadriceps Muscle in Cirrhosis. Comment to "Frailty, sarcopenia and mortality in cirrhosis: What is the best assessment, how to interpret the data correctly and what interventions are possible?"
    Clin Res Hepatol Gastroenterol. 2021 Jun 1:101727.
    PubMed    
    
    
    May 2021
76. KARNSAKUL W, Wasuwanich P, Ingviya T, Laengvejkal P, et al
    Clinical usage of serum albumin to ascitic fluid albumin gradient and ascitic fluid total protein in pediatric ascites.
    Clin Res Hepatol Gastroenterol. 2021;45:101549.
    PubMed     Abstract available
    
    
    
77. KULKARNI AV, Tevethia HV, Arab JP, Candia R, et al
    Efficacy and safety of obeticholic acid in liver disease-A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2021;45:101675.
    PubMed     Abstract available
    
    
    April 2021
78. OZCELIK F
    Prognostic value of gamma-glutamyl transpeptidase in liver cirrhosis and hepatocellular cancer regardless of other parameters.
    Clin Res Hepatol Gastroenterol. 2021 Apr 27:101708.
    PubMed    
    
    
    
79. CARDOSO CC, Matiollo C, Pereira CHJ, Fonseca JS, et al
    B-cell compartment abnormalities are associated with ACLF and mortality in patients with liver cirrhosis.
    Clin Res Hepatol Gastroenterol. 2021 Apr 11:101698.
    PubMed     Abstract available
    
    
    March 2021
80. TORNAI D, Vitalis Z, Jonas A, Janka T, et al
    Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality.
    Clin Res Hepatol Gastroenterol. 2021;45:101579.
    PubMed     Abstract available
    
    
    
81. CAO X, Cao Z, Ou C, Zhang L, et al
    Combination of serum paraoxonase/arylesterase 1 and antithrombin-III is a promising non-invasion biomarker for discrimination of AFP-negative HCC versus liver cirrhosis patients.
    Clin Res Hepatol Gastroenterol. 2021;45:101583.
    PubMed     Abstract available
    
    
    
82. CORPECHOT C
    The revival of preemptive UDCA therapy in liver transplant recipients: Commentary to "UDCA decreases Incidence of Primary Biliary Cholangitis and Biliary Complications after Liver Transplant: A Meta-Analysis" by Pedersen et al., Liver Transplant, Nove
    Clin Res Hepatol Gastroenterol. 2021 Mar 13:101679.
    PubMed    
    
    
    
83. LANTHIER N, Starkel P, Dahlqvist G
    Frailty, sarcopenia and mortality in cirrhosis: what is the best assessment, how to interpret the data correctly and what interventions are possible?
    Clin Res Hepatol Gastroenterol. 2021 Mar 2:101661.
    PubMed     Abstract available
    
    
    
84. DI GIORGIO A, Nicastro E, Arnaboldi S, Montini O, et al
    "Health status of children with chronic liver disease during the SARS-CoV-2 outbreak: results from a multicentre study".
    Clin Res Hepatol Gastroenterol. 2021;45:101610.
    PubMed    
    
    
    
85. LIU Y, Wu H, Wang Z, Wu J, et al
    Integrated expression profiles of mRNA and miRNA in a gerbil model of fatty liver fibrosis treated with exenatide.
    Clin Res Hepatol Gastroenterol. 2021;45:101312.
    PubMed     Abstract available
    
    
    
86. XIE Z, Wu Y, Liu S, Lai Y, et al
    LncRNA-SNHG7/miR-29b/DNMT3A axis affects activation, autophagy and proliferation of hepatic stellate cells in liver fibrosis.
    Clin Res Hepatol Gastroenterol. 2021;45:101469.
    PubMed     Abstract available
    
    
    
87. XIE X, Feng Y, Lyu Z, Wang L, et al
    Liver stiffness as measured by two-dimensional shear wave elastography overestimates the stage of fibrosis in patients with chronic hepatitis B and hepatic steatosis.
    Clin Res Hepatol Gastroenterol. 2021;45:101421.
    PubMed     Abstract available
    
    
    February 2021
88. GAO Y, Liu H, Tang F, Zhang X, et al
    Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2021 Feb 15:101649.
    PubMed     Abstract available
    
    
    January 2021
89. ZHAO N, Liu X, Guo H, Zhao X, et al
    Interleukin-35: An emerging player in the progression of liver diseases.
    Clin Res Hepatol Gastroenterol. 2021;45:101518.
    PubMed     Abstract available
    
    
    
90. ALLAIRE M, El Hajj W, Brichler S, Diallo K, et al
    Prior surveillance and antiviral treatment improve the prognosis of HCC developed in HBV patients in the West.
    Clin Res Hepatol Gastroenterol. 2021;45:101436.
    PubMed     Abstract available
    
    
    
91. KANG Y, Park S, Kim S, Han SJ, et al
    Validating the BAVENO VI criteria to identify low risk biliary atresia patients without endoscopy for esophageal varix.
    Clin Res Hepatol Gastroenterol. 2021;45:101437.
    PubMed     Abstract available
    
    
    
92. RAFFETTI E, Portolani N, Molfino S, Mentasti S, et al
    Is survival for hepatocellular carcinoma increasing? A population-based study on survival of hepatocellular carcinoma patients in the 1990s and 2000s.
    Clin Res Hepatol Gastroenterol. 2021;45:101433.
    PubMed     Abstract available
    
    
    November 2020
93. HUANG C, Seah JJ, Tan CK, Kam JW, et al
    Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease.
    Clin Res Hepatol Gastroenterol. 2020 Nov 29:101528.
    PubMed     Abstract available
    
    
    December 2019
94. PETIT PR, Borentain P, Aherfi S, Gerolami R, et al
    Hepatitis Delta recurrence post-liver transplantation in absence of detectable hepatitis B surface antigen and hepatitis B virus DNA in peripheral blood.
    Clin Res Hepatol Gastroenterol. 2019 Dec 28. pii: S2210-7401(19)30258.
    PubMed    
    
    
    June 2019
95. LIBERAL R, Gaspar R, Lopes S, Macedo G, et al
    Primary biliary cholangitis in patients with inflammatory bowel disease.
    Clin Res Hepatol Gastroenterol. 2019 Jun 3. pii: S2210-7401(19)30099.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.